Megakaryoblastic Leukemia Factor-1 Transduces Cytoskeletal Signals and Induces Smooth Muscle Cell Differentiation from Undifferentiated Embryonic Stem Cells*
Kevin Du,Mary Chen,Jian Li,John J. Lepore,Patricia Mericko,Michael S. Parmacek
DOI: https://doi.org/10.1074/jbc.m400961200
2004-01-01
Abstract:The SAP domain transcription factor myocardin plays a critical role in the transcriptional program regulating smooth muscle cell differentiation. In this report, we describe the capacity of myocardin to physically associate with megakaryoblastic leukemia factor-1 (MKL1) and characterize the function of MKL1 in smooth muscle cells (SMCs). The MKL1 gene is expressed in most human tissues and myocardin and MKL are co-expressed in SMCs. MKL1 and myocardin physically associate via conserved leucine zipper domains. Overexpression of MKL1 transactivates serum response factor (SRF)-dependent SMC-restricted transcriptional regulatory elements including the SM22α promoter, smooth muscle myosin heavy chain promoter/enhancer, and SM-α-actin promoter/enhancer in non-SMCs. Moreover, forced expression of MKL1 and SRF in undifferentiated SRF-/- embryonic stem cells activates multiple endogenous SMC-restricted genes at levels equivalent to, or exceeding, myocardin. Forced expression of a dominant-negative MKL1 mutant reduces myocardin-induced activation of the SMC-specific SM22α promoter. In NIH3T3 fibroblasts MKL1 localizes to the cytoplasm and translocates to the nucleus in response to serum stimulation, actin treadmilling, and RhoA signaling. In contrast, in SMCs MKL1 is observed exclusively in the nucleus regardless of serum conditions or RhoA signaling. However, when actin polymerization is disrupted MKL1 translocates from the nucleus to the cytoplasm in SMCs. Together, these data were consistent with a model wherein MKL1 transduces signals from the cytoskeleton to the nucleus in SMCs and regulates SRF-dependent SMC differentiation autonomously or in concert with myocardin. The SAP domain transcription factor myocardin plays a critical role in the transcriptional program regulating smooth muscle cell differentiation. In this report, we describe the capacity of myocardin to physically associate with megakaryoblastic leukemia factor-1 (MKL1) and characterize the function of MKL1 in smooth muscle cells (SMCs). The MKL1 gene is expressed in most human tissues and myocardin and MKL are co-expressed in SMCs. MKL1 and myocardin physically associate via conserved leucine zipper domains. Overexpression of MKL1 transactivates serum response factor (SRF)-dependent SMC-restricted transcriptional regulatory elements including the SM22α promoter, smooth muscle myosin heavy chain promoter/enhancer, and SM-α-actin promoter/enhancer in non-SMCs. Moreover, forced expression of MKL1 and SRF in undifferentiated SRF-/- embryonic stem cells activates multiple endogenous SMC-restricted genes at levels equivalent to, or exceeding, myocardin. Forced expression of a dominant-negative MKL1 mutant reduces myocardin-induced activation of the SMC-specific SM22α promoter. In NIH3T3 fibroblasts MKL1 localizes to the cytoplasm and translocates to the nucleus in response to serum stimulation, actin treadmilling, and RhoA signaling. In contrast, in SMCs MKL1 is observed exclusively in the nucleus regardless of serum conditions or RhoA signaling. However, when actin polymerization is disrupted MKL1 translocates from the nucleus to the cytoplasm in SMCs. Together, these data were consistent with a model wherein MKL1 transduces signals from the cytoskeleton to the nucleus in SMCs and regulates SRF-dependent SMC differentiation autonomously or in concert with myocardin. Smooth muscle cells (SMCs) 1The abbreviations used are: SMC, smooth muscle cell; SRF, serum response factor; TCF, ternary complex factor; SM-MHC, smooth muscle-myosin heavy chain; ES, embryonic stem; MRTF, myocardin-related transcription factor; MKL1, megakaryoblastic leukemia factor-1; HA, hemagglutinin; LZ, leucine zipper; CRE, cyclic AMP response element; RT, reverse transcriptase; ChIP, chromatin immunoprecipitation; FL-Myo, FLAG epitope-tagged myocardin; DN, dominant-negative; C(t), cycle threshold; X-Gal, 5-bromo-4-chloro-3-indolyl-β-d-galactopyranoside. are distributed in organ systems and tissues throughout the body where they regulate tonic contractile functions including modulation of vascular tone, bronchial reactivity, gastrointestinal peristalsis, and genitourinary contraction and tone. In contrast to striated muscle cells, SMCs retain the capacity to both proliferate and modulate their phenotype from contractile to synthetic during postnatal development. The plasticity and proliferative capacity of this muscle cell lineage plays a central role in physiological processes including wound healing and angiogenesis. However, modulation of SMC phenotype has also been implicated in the pathogenesis of disease processes including atherosclerosis, restenosis following coronary angioplasty/stent implantation, and asthma. Our group and others have reported that SMC differentiation and modulation of the SMC phenotype is regulated by a serum response factor (SRF)-dependent transcriptional regulatory program (for review see Refs. 1Parmacek M.S. Curr. Top. Dev. Biol. 2001; 51: 69-89Crossref PubMed Google Scholar and 2Miano J.M. J. Mol. Cell. Cardiol. 2003; 35: 577-593Abstract Full Text Full Text PDF PubMed Scopus (488) Google Scholar)). SRF is a MADS box transcription factor that binds to a transcriptional regulatory element designated the CArG box or SRE. The functional properties of SRF and SRF binding sites were initially characterized in promoters regulating growth responsive genes including c-fos and egr-1 (3Treisman R. EMBO J. 1995; 14: 4905-4913Crossref PubMed Scopus (347) Google Scholar, 4Treisman R. Nature. 1995; 376: 468-469Crossref PubMed Scopus (31) Google Scholar, 5Johansen F.E. Prywes R. Biochim. Biophys. Acta. 1995; 1242: 1-10Crossref PubMed Scopus (105) Google Scholar). SRF-mediated activity of growth responsive genes is regulated via post-translational modifications of SRF and ternary complex factors (TCFs) in the ets family that physically associate with both SRF and specific DNA sequences (6Treisman R. Curr. Opin. Genet. Dev. 1994; 4: 96-101Crossref PubMed Scopus (620) Google Scholar). SRF activity is also modulated by intracellular signals including serum, RhoA, and actin treadmilling (7Sotiropoulos A. Gineitis D. Copeland J. Treisman R. Cell. 1999; 98: 159-169Abstract Full Text Full Text PDF PubMed Scopus (574) Google Scholar, 8Treisman R. Alberts A.S. Sahai E. Cold Spring Harbor Symp. Quant. Biol. 1998; 63: 643-651Crossref PubMed Scopus (67) Google Scholar, 9Hill C.S. Wynne J. Treisman R. Cell. 1995; 81: 1159-1170Abstract Full Text PDF PubMed Scopus (1207) Google Scholar, 10Mack C.P. Somlyo A.V. Hautmann M. Somlyo A.P. Owens G.K. J. Biol. Chem. 2001; 276: 341-347Abstract Full Text Full Text PDF PubMed Scopus (333) Google Scholar). Functionally important CArG boxes have been identified in all SMC-restricted transcriptional regulatory elements (1Parmacek M.S. Curr. Top. Dev. Biol. 2001; 51: 69-89Crossref PubMed Google Scholar, 2Miano J.M. J. Mol. Cell. Cardiol. 2003; 35: 577-593Abstract Full Text Full Text PDF PubMed Scopus (488) Google Scholar). Mutation of these CArG boxes abolishes activity of these transcriptional elements. A multimerized copy of the SME-4 CArG box embedded in the SMC-restricted SM22α promoter is sufficient to restrict expression of a reporter gene to arterial SMCs in transgenic mice (11Kim S. Ip H.S. Lu M.M. Clendenin C. Parmacek M.S. Mol. Cell. Biol. 1997; : 2266-2278Crossref PubMed Scopus (190) Google Scholar). Until recently it was not clear how a ubiquitously expressed transcription factor such as SRF could regulate transcription of both growth responsive genes and muscle-restricted differentiation markers. Recent studies revealed that SRF regulates SMC differentiation via direct binding to the recently discovered cardiac- and SMC-restricted SAP (SAF-A/B, Acinus, PIAS) domain transcription factor myocardin (12Chen J. Kitchen C.M. Streb J.W. Miano J.M. J. Mol. Cell. Cardiol. 2002; 34: 1345-1356Abstract Full Text PDF PubMed Google Scholar, 13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar, 14Li S. Wang D.Z. Wang Z. Richardson J.A. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 9366-9370Crossref PubMed Scopus (301) Google Scholar, 15Wang Z. Wang D.Z. Pipes G.C. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 7129-7134Crossref PubMed Scopus (432) Google Scholar, 16Yoshida T. Sinha S. Dandre F. Wamhoff B.R. Hoofnagle M.H. Kremer B.E. Wang D.Z. Olson E.N. Owens G.K. Circ. Res. 2003; 92: 856-864Crossref PubMed Scopus (310) Google Scholar). Myocardin is a member of an ancient, and diverse, family of SAP domain-containing proteins that have been implicated in high order chromatin organization, apoptotic nuclear condensation and, most recently, RhoA-actin signal transduction (17Miralles F. Posern G. Zaromytidou A.I. Treisman R. Cell. 2003; 113: 329-342Abstract Full Text Full Text PDF PubMed Scopus (1057) Google Scholar, 18Wang D. Chang P.S. Wang Z. Sutherland L. Richardson J.A. Small E. Krieg P.A. Olson E.N. Cell. 2001; 105: 851-862Abstract Full Text Full Text PDF PubMed Scopus (752) Google Scholar, 19Wang D.Z. Li S. Hockemeyer D. Sutherland L. Wang Z. Schratt G. Richardson J.A. Nordheim A. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 14855-14860Crossref PubMed Scopus (405) Google Scholar, 20Aravind L. Koonin E.V. Trends Biochem. Sci. 2000; 25: 112-114Abstract Full Text Full Text PDF PubMed Scopus (415) Google Scholar). Forced expression of myocardin activates SMC-restricted transcriptional regulatory elements in non-SMC cells including the SM22α promoter, the smooth muscle myosin heavy chain (SM-MHC) promoter/intragenic enhancer, and the SM-α-actin promoter/intragenic enhancer (12Chen J. Kitchen C.M. Streb J.W. Miano J.M. J. Mol. Cell. Cardiol. 2002; 34: 1345-1356Abstract Full Text PDF PubMed Google Scholar, 13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar, 15Wang Z. Wang D.Z. Pipes G.C. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 7129-7134Crossref PubMed Scopus (432) Google Scholar, 16Yoshida T. Sinha S. Dandre F. Wamhoff B.R. Hoofnagle M.H. Kremer B.E. Wang D.Z. Olson E.N. Owens G.K. Circ. Res. 2003; 92: 856-864Crossref PubMed Scopus (310) Google Scholar). Moreover, forced expression of myocardin and SRF in SRF-deficient embryonic stem (ES) cells activates endogenous SMC genes including SM22α, SM-MHC, calponin-h1, and SM-α-actin (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar). Mice harboring a mutation in the myocardin gene die at embryonic day (E)10.5 of gestation and differentiated vascular SMCs are not observed (14Li S. Wang D.Z. Wang Z. Richardson J.A. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2003; 100: 9366-9370Crossref PubMed Scopus (301) Google Scholar). Several important questions related to the role of SRF and myocardin in SMC differentiation remain unanswered. First, is there an alternative factor or pathway that regulates SMC differentiation in the absence of myocardin expression? Of note, in the mouse embryo at E9.5 myocardin is not expressed in the dorsal aorta (at the level of sensitivity afforded by in situ hybridization analyses), but vascular SMCs surrounding the aorta express differentiated markers including SM-α-actin and SM22α (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar). Second, how do intracellular signals that regulate SMC differentiation, including actin treadmilling and RhoA, modulate activity of SRF and/or myocardin in SMCs? Finally, what role if any do the recently identified myocardin-related transcription factors (MRTFs), MKL1/MAL/BSAC/MRTF-A (henceforth designated MKL1) (19Wang D.Z. Li S. Hockemeyer D. Sutherland L. Wang Z. Schratt G. Richardson J.A. Nordheim A. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 14855-14860Crossref PubMed Scopus (405) Google Scholar, 21Ma Z. Morris S.W. Valentine V. Li M. Herbrick J.A. Cui X. Bouman D. Li Y. Mehta P.K. Nizetic D. Kaneko Y. Chan G.C. Chan L.C. Squire J. Scherer S.W. Hitzler J.K. Nat. Genet. 2001; 28: 220-221Crossref PubMed Scopus (246) Google Scholar, 22Mercher T. Coniat M.B. Monni R. Mauchauffe M. Khac F.N. Gressin L. Mugneret F. Leblanc T. Dastugue N. Berger R. Bernard O.A. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 5776-5779Crossref PubMed Scopus (198) Google Scholar, 23Sasazuki T. Sawada T. Sakon S. Kitamura T. Kishi T. Okazaki T. Katano M. Tanaka M. Watanabe M. Yagita H. Okumura K. Nakano H. J. Biol. Chem. 2002; 277: 28853-28860Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar) and MRTF-B/MKL2 (19Wang D.Z. Li S. Hockemeyer D. Sutherland L. Wang Z. Schratt G. Richardson J.A. Nordheim A. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 14855-14860Crossref PubMed Scopus (405) Google Scholar, 24Selvaraj A. Prywes R. J. Biol. Chem. 2003; 278: 41977-41987Abstract Full Text Full Text PDF PubMed Scopus (114) Google Scholar), play in SMCs and other cell lineages? To better understand the molecular mechanisms that regulate activity of myocardin and SRF in SMCs, we performed a two-hybrid screen in yeast using the conserved N terminus of myocardin as bait. Surprisingly, three clones isolated in this screen encoded MKL1. MKL1 was first identified in the chromosomal translocation t (1Parmacek M.S. Curr. Top. Dev. Biol. 2001; 51: 69-89Crossref PubMed Google Scholar, 22Mercher T. Coniat M.B. Monni R. Mauchauffe M. Khac F.N. Gressin L. Mugneret F. Leblanc T. Dastugue N. Berger R. Bernard O.A. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 5776-5779Crossref PubMed Scopus (198) Google Scholar) (p13;q13) associated with acute megakaryoblastic leukemia in infants and children (21Ma Z. Morris S.W. Valentine V. Li M. Herbrick J.A. Cui X. Bouman D. Li Y. Mehta P.K. Nizetic D. Kaneko Y. Chan G.C. Chan L.C. Squire J. Scherer S.W. Hitzler J.K. Nat. Genet. 2001; 28: 220-221Crossref PubMed Scopus (246) Google Scholar, 22Mercher T. Coniat M.B. Monni R. Mauchauffe M. Khac F.N. Gressin L. Mugneret F. Leblanc T. Dastugue N. Berger R. Bernard O.A. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 5776-5779Crossref PubMed Scopus (198) Google Scholar, 23Sasazuki T. Sawada T. Sakon S. Kitamura T. Kishi T. Okazaki T. Katano M. Tanaka M. Watanabe M. Yagita H. Okumura K. Nakano H. J. Biol. Chem. 2002; 277: 28853-28860Abstract Full Text Full Text PDF PubMed Scopus (82) Google Scholar). Recently, MKL1 has been shown to regulate the transcriptional activity of SRF in fibroblasts, via nuclear translocation in response to serum, RhoA, and actin treadmilling (17Miralles F. Posern G. Zaromytidou A.I. Treisman R. Cell. 2003; 113: 329-342Abstract Full Text Full Text PDF PubMed Scopus (1057) Google Scholar, 25Cen B. Selvaraj A. Burgess R.C. Hitzler J.K. Ma Z. Morris S.W. Prywes R. Mol. Cell. Biol. 2003; 23: 6597-6608Crossref PubMed Scopus (248) Google Scholar). In the studies described in this report, we show that myocardin and MKL1 physically associate via conserved leucine zipper domains. In addition, we demonstrate that MKL1 is expressed in SMCs and examine the signaling pathways regulating nuclear versus cytoplasmic localization of MKL1 in SMCs. Finally, we demonstrated that, like myocardin, MKL1 activates transcriptional regulatory elements controlling SMC-restricted genes and activates endogenous SMC genes in undifferentiated ES cells via SRF-dependent mechanisms. Plasmids—The pcDNA3-MKL1 expression plasmid encoding human MKL1 was generated by subcloning the coding region of the human MKL1 cDNA into pcDNA3 (Invitrogen). The pcDNA3.1-myocardin and pcDNA3-SRF expression plasmids encoding human myocardin and SRF have been described previously (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar). The pcR3.1-HA-MKL1 and pcDNA3.1-FLAG-MKL1 expression plasmids encoding HA and FLAG epitope-tagged human MKL1, respectively, were generated by subcloning the human MKL1 cDNA into pcR3.1 (Invitrogen) and pcDNA3.1 (Invitrogen), respectively. pcR3.1-myc-myocardin and pcDNA3.1-FLAG-myocardin encoding myc and FLAG epitope-tagged myocardin, respectively, were generated by subcloning the human myocardin cDNA into pcR3.1 (Invitrogen) or pcDNA3.1 (Invitrogen), respectively. The pcDNA-MyoCΔ585 and pcDNA-MyoCΔ381 expression plasmids encoding the N-terminal 585 and 381 amino acids of human myocardin were generated by subcloning each respective myocardin cDNA subfragment into pcDNA3. pcDNA3.1-FLAG-MyoΔLZ expression plasmid is identical to the pcDNA3.1-FLAG myocardin plasmid except the cDNA sequence encoding the myocardin leucine zipper (LZ) domain (amino acids 519–549) was deleted. The p-441.luc reporter plasmid contains the 441-bp mouse SM22α promoter (bp -441 to +41) subcloned into pGL2-Basic (Promega) as described (11Kim S. Ip H.S. Lu M.M. Clendenin C. Parmacek M.S. Mol. Cell. Biol. 1997; : 2266-2278Crossref PubMed Scopus (190) Google Scholar). The p-441μCArG. luc reporter is identical to the -441.luc reporter plasmid except that the underlined nucleotides in SME-1 (5′-TCCTGCCCATAGATCTTTTTTCC-3′) and SME-4 (5′-GCTCCAACTTGGTGTCTTTCCCCGGATATGGAGCCT-3′) were mutated to abolish SRF binding (11Kim S. Ip H.S. Lu M.M. Clendenin C. Parmacek M.S. Mol. Cell. Biol. 1997; : 2266-2278Crossref PubMed Scopus (190) Google Scholar). pSME4-luc contains four copies of the mouse SM22α SME-4 CArG box-containing nuclear protein binding site (bp -173 to -136) subcloned immediately 5′ of the minimal promoter in pLuc-MCS (Stratagene) (26Strobeck M. Kim S. Zhang J.C. Clendenin C. Du K.L. Parmacek M.S. J. Biol. Chem. 2001; 276: 16418-16424Abstract Full Text Full Text PDF PubMed Scopus (38) Google Scholar). The pPI-Act.luc and pPI-MHC.luc luciferase reporter plasmids containing the SM-α-actin and SM-MHC promoter and intragenic enhancers, respectively, subcloned into pGL3-Basic, were the generous gift of Dr. Gary Owens (University of Virginia) and have been described previously (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar). pSRE-luc contains four copies of the c-fos SRE subcloned immediately 5′ of the minimal promoter pLuc-MCS. pCRE-luc contains four copies of a consensus cyclic AMP response element (CRE) (27Lee K.A. Masson N. Biochim. Biophys. Acta. 1993; 1174: 221-233Crossref PubMed Scopus (189) Google Scholar), subcloned 5′ of the minimal promoter in pLuc-MCS. pGBKT7-MyoCΔ585 encodes the N-terminal 585 amino acid residues of myocardin, subcloned in-frame to the GAL4 binding domain of pGBKT7 (Clontech). The pRK5-myc-RhoA N19 expression plasmid encodes a dominant-negative RhoA mutant and was a generous gift from Professor Alan Hall (University College London). Yeast Two-hybrid Screen—pGBKT7-MyoCΔ585 was transformed into yeast strain AH109 to generate the bait strain. >5 × 109 of the bait strain cells were mated with >1.6 × 108 colony forming units of the pre-transformed Human Heart MATCHMAKER library (Clontech) and plated onto SD-Ade/-His/-Leu/-Trp/+X-α-Gal agar plates. Positive clones were identified by growth on SD-Ade/-His/-Leu/-Trp/+X-α-Gal agar plates. 5.1 × 105 transformants were screened based on colony size and intensity of X-Gal staining, and plasmid was recovered from the colonies and sequenced as recommended by the manufacturer (Clontech). Three clones corresponding to the full-length open reading frame of MKL1 were isolated and characterized further. Co-immunoprecipitation Assays—In vitro transcription reactions and translations were performed using pcDNA-MyoCΔ585, pcDNA-MyoCΔ381, pcDNA3.1-MyoΔLZ, and pcDNA3.1-FLAG-MKL1, respectively, as templates and the TnT Quick Coupled Transcription/Translation System (Promega). Myocardin and each deletion mutant were labeled with biotinylated-lysyl-tRNA (Transcend tRNA, Promega). Unlabeled FLAG-MKL1, biotinylated myocardin, and 40 μl of EZview Red anti-FLAG M2 affinity gel (Sigma) were incubated at 4 °C for 12–16 h. Protein bound to the anti-FLAG M2 antibody was isolated and the immunoprecipitated protein was electrophoretically separated by SDS-PAGE, transferred to polyvinylidene difluoride membrane, and visualized with streptavidin-horseradish peroxidase and a chemiluminescent substrate (Promega). Northern Blot Analyses—Northern blot analyses were performed using the Human 12-lane MTN, Human Muscle MTN, and Human Cardiovascular MTN blots prepared by Clontech as described previously (28Parmacek M.S. Leiden J.M. J. Biol. Chem. 1989; 264: 13217-13225Abstract Full Text PDF PubMed Google Scholar). In addition, Northern blot analyses were performed on membranes containing 10 μg/lane of total RNA harvested from wild-type ES cells, NIH3T3 cells, C3H10T1/2 cells, C2C12 myoblasts, A10 SMCs, PAC1 SMCs, and primary rat aortic SMCs, respectively, as described previously (28Parmacek M.S. Leiden J.M. J. Biol. Chem. 1989; 264: 13217-13225Abstract Full Text PDF PubMed Google Scholar). The 32P-labeled human and mouse MKL1 cDNA probes were generated by random primed labeling as described previously (28Parmacek M.S. Leiden J.M. J. Biol. Chem. 1989; 264: 13217-13225Abstract Full Text PDF PubMed Google Scholar). Cell Culture, Transient Co-transfections, and Luciferase Assays— COS-7 cells were grown as described previously (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar). Transient co-transfection of 1 × 105 COS-7 cells were performed with FuGENE 6 (Roche Diagnostics) and 200 ng to 1 μg of the indicated luciferase reporter plasmid, 100–200 ng of the indicated expression plasmid, and 10 ng of the phRL-TK (-Int) reference plasmid (Promega). Luciferase activity was measured and normalized for transfection efficiency using the Dual Luciferase Assay system (Promega). Data are reported as mean normalized relative light units ± S.E. SRF-/- ES cells (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar) were grown and transfected with LipofectAMINE 2000 (Invitrogen) as described previously (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar). NIH3T3 cells, A7r5 SMCs, C3H10T1/2 cells, A10 SMCs, and PAC1 SMCs ATCC were grown as described previously (29Solway J. Seltzer J. Samaha F.F. Kim S. Alger L.E. Niu Q. Morrisey E.E. Ip H.S. Parmacek M.S. J. Biol. Chem. 1995; 270: 13460-13469Abstract Full Text Full Text PDF PubMed Scopus (227) Google Scholar). Transfection of ES Cells and Real Time Reverse Transcriptase (RT)-PCR—1 × 106 SRF-/- ES cells (13Du K.L. Ip H.S. Li J. Chen M. Dandre F. Yu W. Lu M.M. Owens G.K. Parmacek M.S. Mol. Cell. Biol. 2003; 23: 2425-2437Crossref PubMed Scopus (312) Google Scholar) were co-transfected with LipofectAMINE 2000 (Invitrogen) and either 4 μg of pcDNA3-myocardin plus 10 ng of pcDNA3-SRF, 4 μg of pcDNA3-MKL1 plus 10 ng of pcDNA3-SRF, or 4 μg of pcDNA3 plus 10 ng of pcDNA3-SRF. 24 h post-transfection, RNA was harvested from the cells for real time RT-PCR with TRIzol (Invitrogen). PCR were performed with 5 μl of reverse transcribed cDNA reaction mixture, 400 nm of specific forward and reverse primers and 1× SYBR Green PCR Master Mix (Applied Biosystems). The following primer pairs were utilized: (i) SM-α-actin, 5′-GAGAAGCCCAGCCAGTCG-3′ and 5′-CTCTTGCTCTGGGCTTCA-3′; (ii) myocardin, 5′-CTGTGTGGAGTCCTCAGGTCAAACC-3′ and 5′-GATGTGCTGCGGGCTCTTCAG-3′; (iii) calponin-h1, 5′-CCCAGAAATACGACCATCAGCG-3′ and 5′-CACCCCCTCAATCCACTCTCTCAG-3′; (iv) SM22α, 5′-AGCCAGTGAAGGTGCCTGAGAAC-3′ and 5′-TGCCCAAAGCCATTAGAGTCCTC-3′; (v) SM-MHC, 5′-TGGACACCATGTCAGGGAAA-3′ and 5′-ATGGACACAAGTGCTAAGCAGTCT-3′; (vi) glyceraldehyde-3-phosphate dehydrogenase, 5′-GTGGCAAAGTGGAGATTGTTGCC-3′ and 5′-GATGATGACCCGTTTGGCTCC-3′. Quantification of the reaction product was performed using the MJ Research DNA Engine Opticon 2 real time detection system. PCR cycle conditions were 95 °C for 10 min, followed by 40 cycles of denaturation at 95 °C for 15 s and annealing and extension at 60 °C for 1 min. All RT and PCR were performed in triplicate with and without RT as controls. Cycle threshold (C(t)) values were converted to relative gene expression levels using the 2-ΔΔC(t) method (30Livak K.J. Schmittgen T.D. Methods (Orlando). 2001; 25: 402-408Crossref Scopus (124899) Google Scholar). Chromatin Immunoprecipitation (ChIP) Assays—ChIP assays were performed using the protocol described by Owens and colleagues (31Manabe I. Owens G.K. Circ. Res. 2001; 88: 1127-1134Crossref PubMed Scopus (143) Google Scholar). SRF-/- ES cells were transiently transfected with pcDNA3.1, pcDNA3.1-FLAG-Myo, pcDNA3.1-FLAG-MyoΔLZ, pcDNA3.1-FLAG-Myo plus pcDNA3-SRF, or pcDNA3.1-FLAG-MyoΔLZ plus pcDNA3-SRF, respectively. 24 h post-transfection, cells were fixed in 1% formaldehyde, lysed in 1% SDS, 10 mm EDTA, and 50 mm Tris-HCl, pH 8.1, with mammalian proteinase inhibitors (Sigma) and sonicated. Each cell lysate was diluted 10-fold, incubated overnight with anti-FLAG M2 antibody (Sigma), and 90 μg of Protein A-agarose was added to each sample. Immunoprecipitated, reverse cross-linked DNA was recovered by phenol/chloroform extraction and in turn was subject to PCR analysis with primers flanking the SME-4 CArG box containing the nuclear protein binding site in the mouse SM22α promoter (5′-GGTCCTGCCCATAAAAGGTTT-3′ and 5′-TGCCCATGGAAGTCTGCTTGG-3′) designed to generate a 200-bp amplified DNA fragment. Immunohistochemistry—The intracellular location of myocardin and MKL1 was determined by transiently co-transfecting primary rat aortic SMCs, A7r5 SMCs, and NIH3T3 cells with 1 μg of pcR3.1-HA-MKL, pcR3.1-myc-myocardin, or the control pcDNA3 expression vector with FuGENE 6 (Roche). 24 h post-transfection cells were serum-starved for 48 h in Dulbecco's modified Eagle's medium supplemented with 0.1% fetal bovine serum. Subsequently, the cells were either maintained in 0.1% fetal bovine serum or serum-stimulated with Dulbecco's modified Eagle's medium supplemented with 20% fetal bovine serum for 1 h. To determine the effect of actin polymerization on the intracellular localization of MKL1, cells were treated for 1 h with 0.5 × 10-6m latrunculin B (Alexis), which inhibits polymerization of actin filaments (32Zhang J.C. Helmke B.P. Shum A. Du K. Yu W.W. Lu M.M. Davies P.F. Parmacek M.S. Mech. Dev. 2002; 115: 161-166Crossref PubMed Scopus (26) Google Scholar). To promote actin polymerization, cells were treated for 1 h with 0.5 × 10-6m jasplakinolide (Molecular Probes) (32Zhang J.C. Helmke B.P. Shum A. Du K. Yu W.W. Lu M.M. Davies P.F. Parmacek M.S. Mech. Dev. 2002; 115: 161-166Crossref PubMed Scopus (26) Google Scholar). To determine the effect of RhoA signaling on the intracellular localization of MKL1, cells were transfected with the pRK5-myc-RhoA N19 expression plasmid encoding a dominant-negative RhoA mutant protein. The cells were then fixed, permeabilized, incubated with primary and secondary antibodies, and visualized on a Zeiss Axiophot microscope as described previously (32Zhang J.C. Helmke B.P. Shum A. Du K. Yu W.W. Lu M.M. Davies P.F. Parmacek M.S. Mech. Dev. 2002; 115: 161-166Crossref PubMed Scopus (26) Google Scholar). MKL1 Physically Associates with Myocardin—To examine the molecular mechanisms regulating myocardin activity, a yeast two-hybrid screen of a human heart cDNA yeast expression library was performed using a yeast indicator strain expressing the N terminus (amino acids 1–585) of the human myocardin protein as bait. The N terminus of myocardin was utilized because this region of the protein includes the evolutionarily conserved and functionally important RPEL, glutamine-rich, basic and SAP domains that have been implicated in regulating activity of myocardin (Fig. 1A and Ref. 18Wang D. Chang P.S. Wang Z. Sutherland L. Richardson J.A. Small E. Krieg P.A. Olson E.N. Cell. 2001; 105: 851-862Abstract Full Text Full Text PDF PubMed Scopus (752) Google Scholar). Positive clones were identified by growth on SD-Ade/-His/-Leu/-Trp/+X-α-Gal agar plates. Three of the 58 isolates contained an ∼4-kb cDNA insert that corresponded to the full-length coding region (open reading frame) of human MKL1/MAL/MRTF-A protein (19Wang D.Z. Li S. Hockemeyer D. Sutherland L. Wang Z. Schratt G. Richardson J.A. Nordheim A. Olson E.N. Proc. Natl. Acad. Sci. U. S. A. 2002; 99: 14855-14860Crossref PubMed Scopus (405) Google Scholar, 21Ma Z. Morris S.W. Valentine V. Li M. Herbrick J.A. Cui X. Bouman D. Li Y. Mehta P.K. Nizetic D. Kaneko Y. Chan G.C. Chan L.C. Squire J. Scherer S.W. Hitzler J.K. Nat. Genet. 2001; 28: 220-221Crossref PubMed Scopus (246) Google Scholar, 22Mercher T. Coniat M.B. Monni R. Mauchauffe M. Khac F.N. Gressin L. Mugneret F. Leblanc T. Dastugue N. Berger R. Bernard O.A. Proc. Natl. Acad. Sci. U. S. A. 2001; 98: 5776-5779Crossref PubMed Scopus (198) Google Scholar). The coding regions of these three clones were identical with differences observed only in the extent of the 5′- and 3′-untranslated regions. A BLAST search of GenBank™ revealed that the human MKL1 gene contains 15 exons spanning 226 kb of sequence on chromosome 1. The 3,907-bp human MKL1 cDNA encodes a 98.9-kDa protein. Sequence analysis revealed that the deduced human MKL1 protein shares 33% homology with myocardin over the entire coding sequence and 70% homology with myocardin across its N-terminal region containing the RPEL, basic, glutamine-rich, SAP, and leucine zipper domains (Fig. 1A). Of note, MKL1